Arjafallah Goulet, Oumniya
Brochard, Charlène
Siproudhis, Laurent
Etienney, Isabelle
Article History
Received: 17 April 2025
Accepted: 16 August 2025
First Online: 10 September 2025
Declarations
:
: Dr. Isabelle Etienney declares having served as a speaker for Takeda, Tillotts, and MSD. Pr. Laurent Siproudhis declares having received educational support from Takeda, AbbVie, Janssen, and Ferring, as well as research support from Takeda and Janssen. Additionally, he has acted as a consultant for Takeda. The other authors declare no conflicts of interest.
: 19th Congress of the European Crohn’s and Colitis Organization (ECCO), 21-24/02, 2024, Stockholm, Sweden.Journées Francophones d’hépato-gastroentérologie et d’oncologie digestive (JFHOD), 14-17/03/2024, Paris, France.